![]() |
||||||||||
|
2008 New Orleans Pediatrics Board Review |
||||||||||
|
Images provided by the
|
The 2008 New Orleans Pediatrics Board Review is scheduled for August 18 - 23, 2008 at the
INTERCONTINENTAL
HOTEL Target Audience: Pediatric residents, practicing pediatricians (recertification now required), and any health care professionals interested in reviewing pertinent basic concepts in pediatrics and the latest information on recent developments in diagnosis and treatment of conditions seen in every day pediatric practice. Initiative Learning Objectives: At the conclusion of this activity, the participant should be better able to 1) Demonstrate increased knowledge of general pediatrics 2) Identify areas of weakness requiring further study 3) Recognize the format and style of board questions 4) Apply the practice test taking skills acquired during the course Accreditation/Designation of Credit: Louisiana State University School of Medicine, New Orleans (LSUSOMNO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. LSUSOMNO designates this educational activity for a maximum of 47AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Facilitated by: The Louisiana State University Health Sciences Center – Institute of Professional Education Faculty Disclosure: It is the policy of the Louisiana State University School of Medicine (LSUSOM) and the Health Sciences Center – Institute of Professional Education (LSUHSC-IPE) to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty participating in continuing medical education activities sponsored by the LSUSOM and facilitated by the LSUHSC-IPE are required to disclose to participants any real or apparent conflict of interest related to the content of their presentations. Disclosure of faculty commercial relationships will be made known at the activity. Faculty are also expected to openly disclose any discussion of off-label and/or investigational uses of drugs in their presentations. |
|||||||||
|
||||||||||